Recent Announcements

SANUWAVE to Present Newest Device, Profile™, at the 20^th Biennial Congress of the International Society of Aesthetic Plastic Surgery

SANUWAVE Health Reports Second Quarter Financial Results and Provides Business Update

SANUWAVE’s PACE Technology Highlighted in Journal of Surgical Research

SANUWAVE Completes Enrollment in dermaPACE Phase III Pivotal IDE Clinical Trial for the Treatment of Diabetic Foot Ulcers . . . SANUWAVE Technology Shown to Successfully Treat Nonunion Fractures of the Tibia . . . SANUWAVE Health Reports on 2009 Financial Results and Progress for the Year . . . SANUWAVE's President and CEO, Christopher M. Cashman, to Present at ROTH Capital Partners 22nd Annual OC Growth Stock Conference on March 17, 2010 . . .

SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures.

SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculation, helping to restore the body's normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.